Immunology, Virology, T cell, Cytotoxic T cell and Viral load are his primary areas of study. His Immunology research incorporates themes from Apoptosis and Receptor. Jean-Pierre Routy has researched Virology in several fields, including Drug resistance and Genotype.
His T cell study combines topics from a wide range of disciplines, such as microRNA, Circulating MicroRNA, Case-control study and Cytokine. His Cytotoxic T cell research incorporates elements of CD8 and Cell biology. His Viral load study which covers Lentivirus that intersects with Superinfection and HIV Antigens.
Jean-Pierre Routy spends much of his time researching Immunology, Virology, Viral load, Immune system and Internal medicine. His work on Immunology is being expanded to include thematically relevant topics such as Cytotoxic T cell. His Virology research includes elements of Antibody, Human leukocyte antigen and Drug resistance.
Jean-Pierre Routy has included themes like Gastroenterology, Oncology and Antiretroviral therapy in his Internal medicine study. His Viral disease study combines topics in areas such as Acquired immunodeficiency syndrome and Immunopathology. His Interleukin 21 research is multidisciplinary, incorporating perspectives in IL-2 receptor and Cell biology.
Jean-Pierre Routy mainly focuses on Immunology, Inflammation, Virology, Internal medicine and Viral load. His study in Immunology is interdisciplinary in nature, drawing from both Receptor and Antiretroviral therapy. The various areas that Jean-Pierre Routy examines in his Virology study include Cell, Cell culture, Epitope, Antibody and Flow cytometry.
His research in Viral load intersects with topics in Tolerability and Drug resistance. His research integrates issues of Cytotoxic T cell, Peripheral blood mononuclear cell, Epithelium and Chromosomal translocation in his study of CD8. His work in the fields of T cell, such as T-cell receptor, overlaps with other areas such as Mechanism.
Jean-Pierre Routy mostly deals with Immunology, Inflammation, Viral load, Internal medicine and CD8. His work carried out in the field of Immunology brings together such families of science as Follicular phase and Chromosomal translocation. As a part of the same scientific study, he usually deals with the Inflammation, concentrating on Gut flora and frequently concerns with Immune system and Disease.
Jean-Pierre Routy combines subjects such as Gastroenterology and Oncology with his study of Internal medicine. His CD8 research integrates issues from Odds ratio and Cytotoxic T cell. As part of one scientific family, Jean-Pierre Routy deals mainly with the area of Receptor, narrowing it down to issues related to the Cell, and often Virology, Viral replication and Flow cytometry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction
Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said.
Nature Medicine (2006)
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar.
The New England Journal of Medicine (2002)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont;Mohamed El-Far;Petronela Ancuta;Lydie Trautmann.
Nature Medicine (2009)
High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection
Bluma G Brenner;Michel Roger;Jean-Pierre Routy;Daniela Moisi.
The Journal of Infectious Diseases (2007)
HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity
Souheil Antoine Younes;Bader Yassine-Diab;Alam R. Dumont;Alam R. Dumont;Mohamed Rachid Boulassel.
Journal of Experimental Medicine (2003)
Towards an HIV cure: a global scientific strategy
Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane.
Nature Reviews Immunology (2012)
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
Elias A. Said;Franck P. Dupuy;Lydie Trautmann;Yuwei Zhang.
Nature Medicine (2010)
Interleukin-2 therapy in patients with HIV infection.
D. Abrams;Y. Lévy;M. H. Losso;A. Babiker.
The New England Journal of Medicine (2009)
HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation
Marie Lise Dion;Jean François Poulin;Rebeka Bordi;Myriam Sylvestre.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: